stockrowLantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.
- Revenue
- +1.54%
- EPS
- −17.1%
- Free cash flow
- +7.71%
- Total debt
- +0.52%
Quarter to September 2026, against a year earlier
Follow LNTH
Alert me
Lantheus Holdings, Inc. (LNTH) Shares outstanding
Lantheus Holdings, Inc.'s shares outstanding at the end of fiscal 2025 was $68.4M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $68.4M. Over the past ten years it has ranged from $24.4M (fiscal 2015) to $71.7M (fiscal 2024); the current reading is higher than 73% of that period. Lantheus Holdings, Inc. ranks 37th of 81 Drug Manufacturers Specialty & Generic companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $68.4M | (4.48%) |
| FY2024 | $71.7M | 2.01% |
| FY2023 | $70.2M | (0.61%) |
| FY2022 | $70.7M | 4.72% |
| FY2021 | $67.5M | 24.66% |
| FY2020 | $54.1M | 34.95% |
| FY2019 | $40.1M | 1.55% |
| FY2018 | $39.5M | 1.57% |
| FY2017 | $38.9M | 19.10% |
| FY2016 | $32.7M | 33.62% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $68.4M | 1.33% |
| Jun 2026 | $67.5M | 2.65% |
| Mar 2026 | $65.8M | (3.90%) |
| Dec 2025 | $68.4M | 1.15% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| RDY Dr. Reddy's Laboratories Ltd compare | $833.3M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $335.7M |
| HIMS Hims & Hers Health, Inc. compare | $231.7M |
| ALKS Alkermes plc compare | $176.4M |
| SUPN Indivior Pharmaceuticals Inc. compare | $122.0M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | $111.2M |
| LQDA Liquidia Corporation compare | $101.4M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $84.9M |
| LNTH Lantheus Holdings, Inc. | $68.4M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on LNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement